IMU 9.26% 5.9¢ imugene limited

Ann: onCARlytics with ARTEMIS T cells show anti-tumour activity, page-32

  1. 113 Posts.
    lightbulb Created with Sketch. 317
    Not so Imugene's Oncarlytics is combination of CF33-CD19t (onCARlytics) as stated in the poster presentation

    We have harnessed this capability of OV and developed a chimeric vaccinia- based OV called CF33-CD19t (onCARlytics) that delivers a non-signaling, truncated CD19 (CD19t) antigen to solid tumors allowing CD19-specific T cells to target them.

    Opinions only

 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.9¢
Change
0.005(9.26%)
Mkt cap ! $433.6M
Open High Low Value Volume
5.4¢ 5.9¢ 5.3¢ $2.269M 39.79M

Buyers (Bids)

No. Vol. Price($)
8 514808 5.8¢
 

Sellers (Offers)

Price($) Vol. No.
5.9¢ 123957 4
View Market Depth
Last trade - 16.10pm 29/08/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.